News and Notes is the online newsletter for NINR: the source for the latest NINR updates of interest to the public, healthcare providers, and our constituents. You may also view recent NINR Press Releases.
Looking for a specific article? Search articles by category and year in the drop-down menus below.
NINR Acting Director, Tara A. Schwetz, PhD and the NINR leadership team have published a message on NINR’s efforts to address racism and promote diversity.
The National Institutes of Health has launched a centralized, secure enclave to store and study vast amounts of medical record data from people diagnosed with coronavirus disease across the country.
NIH is encouraging research to test the implementation of COVID-19 diagnostic testing in underserved or vulnerable communities through the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative.
NINR will host the workshop “Genomic Response to the Social Environment: Implications for Health Outcomes” on June 24, 2020 at 10:00 a.m. EDT.
As part of NIH’s multi-faceted response to the COVID-19 pandemic, NIH has launched an unprecedented four-pronged initiative, entitled Rapid Acceleration of Diagnostics, or RADx, to catalyze the scientific community to improve testing technologies, capacity, and accessibility for the country.
NINR Acting Deputy Director Dr. Jessica Gill and Dr. Kimbra Kenney of the Uniformed Services University of the Health Sciences discussed their research on the American Academy of Neurology’s latest podcast.
NINR Acting Director Dr. Tara Schwetz joined the Oncology Nursing Society's Chief Clinical Officer, Dr. Lisa Kennedy Sheldon, to discuss how Nurse Researchers are responding to the pandemic and NINR’s key initiatives in 2020.
The NIH has issued a new Notice of Intent to Publish for four Funding Opportunity Announcements as part of the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative.
NINR would like to know what nursing research means to our community.
NINR researchers have found that molecules released into the blood following mild traumatic brain injury (TBI) may be indicators of neuronal damage associated with conditions such as post-traumatic stress disorder (PTSD) and depression.